Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Launched by GERMANS TRIAS I PUJOL HOSPITAL · Oct 31, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on studying the safety and quality of a medical procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP). ERCP is used to diagnose and treat problems in the pancreas and bile ducts, which can include conditions like gallstones and certain types of cancer. While generally well-tolerated, ERCP can sometimes lead to complications that may be serious. The goal of this trial is to collect data on patient experiences and the technical aspects of the procedure to better understand these complications and improve the quality of care.

To be eligible for this trial, participants must be adults aged 18 or older who are scheduled to undergo an ERCP at one of the participating centers. They will need to provide their consent to participate. During the study, researchers will record important information about the procedure and monitor patients for any complications that may arise afterward. This trial aims to fill the gap in knowledge about ERCP safety in the Spanish population, and the findings could help enhance the quality of this important procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All consecutive patients who have undergone an ERCP at participating centres from 1 November 2024 will be included. An ERCP will be considered to have been performed when an endoscope is introduced to access the duodenal papilla.
• These included patients must meet all of the following criteria:
• • Over 18 years of age
• • Signed informed consent.
• Exclusion Criteria:
• • Under 18 years of age
• • Unavailability of informed consent
• • Impossibility of follow-up.